6Ipain Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 Cr
as on 17-06-2024
- Revenue 12.37%
(FY 2023)
- Profit 0.43%
(FY 2023)
- Ebitda 26.82%
(FY 2023)
- Net Worth 23.96%
(FY 2023)
- Total Assets 16.78%
(FY 2023)
About 6Ipain Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.40 Cr.
Devender Bhardwaj and Babita Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U24304DL2016PTC306119
- Company No.
306119
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does 6Ipain Healthcare Private Limited offer?
6Ipain Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Anesthetic, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at 6Ipain Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babita Bhardwaj  | Director | 20-Sep-2016 | Current |
| Devender Bhardwaj | Director | 14-Nov-2017 | Current |
Financial Performance of 6Ipain Healthcare.
6Ipain Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.37% increase. The company also saw a slight improvement in profitability, with a 0.43% increase in profit. The company's net worth Soared by an impressive increase of 23.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 6Ipain Healthcare?
In 2022, 6Ipain Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jan 2021 | ₹2.00 Cr | Open |
Yes Bank Limited Creation Date: 26 Oct 2018 | ₹4.00 M | Open |
How Many Employees Work at 6Ipain Healthcare?
6Ipain Healthcare has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 6Ipain Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 6Ipain Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
